Skip to main content
Novartis
language-selector-globe Austria | de
Standort wählen
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Austria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Über Uns 
      • Was wir tun 
        • Unsere Werte 
      • Geschichte 
        • Mehr als 75 Jahre Novartis in Österreich 
      • Forschung & Entwicklung 
      • Management 
      • Standorte in Österreich 
      • Unsere Strategie 
      • Diversity and Inclusion 
      • Arbeiten bei Novartis Österreich 
      • Produkte 
      Über uns Über Uns
    • Betroffene & Angehörige 
      • Unser Versprechen an Patientinnen und Patienten 
      • Patient Engagement 
        • Diabetisches Makulaödem (DMÖ) 
        • Brustkrebs 
        • Altersbedingte Makuladegeneration (AMD) 
        • Erblich bedingte Netzhautdystrophien (IRD) 
        • Webseiten & Apps 
      • Erkrankungen & Therapien 
        • Atemwegserkrankungen 
        • Augenerkrankungen 
        • Dermatologie 
        • Hämatologie 
        • Herz-Kreislauf-Erkrankungen 
        • Onkologie 
        • Rheumatologie 
        • Transplantation 
      • Produkte 
        • Innovative Medikamente 
        • Generika & Biosimilars 
        • Gen & Zelltherapien 
        • Produkte von A-Z 
      • Nebenwirkungen melden 
      • Klinische Studien 
        • Allgemeines 
        • Wissenswertes zu klinischen Studien 
        • Aktuelle Studien 
          • Chronische Myeloische Leukämie in der chronischer Phase (CML-CP): CABL001A2302 
        • Fachausdrücke 
        • Häufig gestellte Fragen zur Studienteilnahme 
        • Onkologische Studien 
      • Fragen & Nebenwirkungen 
        • Meine Fragen - medizinischen Informationsdienst von Novartis 
        • Meine Fragen - Arzt 
        • Meine Fragen - Apotheker 
      • Patientenportal 
      Teaser Patient*innen & Angehörige 280px Betroffene & Angehörige
    • Fachkreise 
      • Serviceportal 
      • Produkte 
      • Novartis Pipeline 
      • Nebenwirkungen melden 
      • Aktuelle Klinische Studien 
      • Novartis Clinical Trials 
      • Terminanfrage 
      Teaser Fachkreise 280px Fachkreise
    • Nachhaltigkeit 
      • Unternehmensethik 
        • Offenlegungen 
      • Zugang zu Medikamenten 
      • Umwelt & Gesellschaft 
      • Ethik, Risiko und Compliance 
        • SpeakUp 
      Nachhaltigkeit Nachhaltigkeit
    • Medien 
      • Pressemitteilungen 
      • Geschichten 
      • Unternehmenspublikationen 
      • Bildmaterial 
      • Medienkontakt 
    • Kontakt 
    • Karriere 
      • Jobsuche 
      • Arbeiten bei Novartis Österreich 
        • Sommer-/Ferialpraktikum 2024 
      • Mitarbeitende 
      • Karriere-Programme 
      • Lehre 
      • Meet the teams 
      Teaser Karriere 525x280px Karriere
    Banner Novartis Medien Startseite
  1. Home
  2. Karriere
  3. Jobsuche
  • Sort by Sort ascending
  • Positionsbezeichnung Sort ascending
  • Site
  • Standort
  • Division
  • Business
  • Functional Area
  • Erscheinungsdatum
Positionsbezeichnung Sort ascending Site Standort Division Business Functional Area Erscheinungsdatum
Associate Director, R&D Portfolio and Engagement - Communications Cambridge (Massachusetts) USA Corporate Affairs CTS Communications & Public Affairs Okt 08, 2024
Associate Director, Political Affairs & Insights Washington, DC USA Corporate Affairs Corporate Communications & Public Affairs Okt 22, 2024
Associate Director, Non-Clinical Statistics Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Okt 11, 2024
Associate Director, Marketing Strategist - Immunology East Hanover USA US Innovative Medicines Marketing Okt 16, 2024
Associate Director, M&A Planning & Integration East Hanover USA Finance Corporate Audit und Finanzen Okt 17, 2024
Associate Director, Integrated Insights, New Products, Oncology East Hanover USA US Innovative Medicines Marketing Okt 17, 2024
Associate Director, Finance and Strategy & Growth Activation Communications East Hanover USA Corporate Affairs CTS Communications & Public Affairs Okt 08, 2024
Associate Director, Digital Analytics - HQ based - East Hanover, NJ East Hanover USA US Innovative Medicines Marketing Okt 09, 2024
Associate Director, Curriculum Design East Hanover USA US Innovative Medicines Der Umsatz Okt 04, 2024
Associate Director, Corporate Event Marketing East Hanover (New Jersey) USA Corporate Affairs CTS Communications & Public Affairs Okt 22, 2024
Associate Director, Clinical QA East Hanover USA Development Innovative Medicines Quality Sep 24, 2024
Associate Director, Access & Reimbursement RLT, Seattle, WA - Remote Field Non-Sales (USA) USA US Innovative Medicines Market Access Jul 19, 2024
Associate Director, Access & Reimbursement RLT - San Diego, CA - Remote Field Non-Sales (USA) USA US Innovative Medicines Market Access Okt 17, 2024
Associate Director, Access & Reimbursement Oncology - Remote - TX,OK, AR Field Non-Sales (USA) USA US Innovative Medicines Market Access Okt 16, 2024
Associate Director Commercial Analytics (Cardiovascular) Distant Employee - Distant Working Arrangement (DWA) (USA) USA US Innovative Medicines Marketing Okt 18, 2024
Associate Director / Director Biotherapeutics (Dual Posting) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Aug 08, 2024
Associate Clinical Research Medical Director - Oncology RLT Remote Position (USA) USA Development Innovative Medicines Research & Development Aug 29, 2024
Asset Strategy Lead – Biologics Analysis Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 27, 2024
Asset Strategy Lead – Automation Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 27, 2024
Allergy-Territory Account Specialist – Wichita, KS – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 24, 2024
Allergy-Territory Account Specialist – Toldeo, OH – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 13, 2024
Allergy-Territory Account Specialist – Seattle E, WA – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Okt 11, 2024
Allergy-Territory Account Specialist – Portland, OR – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 08, 2024
Allergy-Territory Account Specialist – Minneapolis, MN – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 09, 2024
Allergy-Territory Account Specialist – Kansas City, MO – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 09, 2024
Allergy-Territory Account Specialist – Green Bay, WI – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Aug 27, 2024
Allergy-Territory Account Specialist – Fort Wayne, IN – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 25, 2024
Allergy-Territory Account Specialist – Flint, MI – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 10, 2024
Allergy-Territory Account Specialist – Ann Arbor, MI – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 10, 2024
Allergy- Territory Account Specialist- Corpus Christi- Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Okt 23, 2024
Allergy- Territory Account Specialist – San Francisco, CA – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 27, 2024
Allergy- Territory Account Specialist – Detroit, MI – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 30, 2024
Allergy- Territory Account Specialist – Akron, OH– Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 10, 2024
Allergy Territory Account Specialist- Fort Worth- Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Okt 22, 2024
Allergy Territory Account Specialist- Austin West- Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Okt 22, 2024
Allergy Territory Account Specialist- Austin East- Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Okt 22, 2024
Allergy Territory Account Specialist – Queens, NY – Remote Queens (New York) USA US Innovative Medicines Der Umsatz Okt 15, 2024
Allergy Territory Account Specialist – Pasadena, CA – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 08, 2024
Allergy Territory Account Specialist - Los Angeles, CA (East) - Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 23, 2024
Allergy Territory Account Specialist - Chicago, IL (South) - Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 11, 2024
Allergy Territory Account Specialist - Chicago, IL (North) - Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 23, 2024
AD, QA, Evaluations and Integrations Cambridge (USA) USA Biomedical Research Pharma Research Quality Okt 25, 2024
AD, Patient Support Center - Program Monitoring Arizona USA US Innovative Medicines Quality Okt 04, 2024
AD, Market Access TA Strategy- Breast & Women's Cancer East Hanover USA US Innovative Medicines Market Access Okt 16, 2024
AD, Case Manager Immunology East Hanover USA US Innovative Medicines Der Umsatz Okt 25, 2024
AD, Access & Reimbursement - Minneapolis - Remote Field Non-Sales (USA) USA US Innovative Medicines Market Access Okt 17, 2024
Access & Reimbursement Manager NPS - Enterprise - Rocky Mountains - Remote Field Non-Sales (USA) USA US Innovative Medicines Der Umsatz Okt 17, 2024
Access & Reimbursement Manager NPS - Enterprise - Great Lakes - Remote Field Non-Sales (USA) USA US Innovative Medicines Der Umsatz Okt 17, 2024
ABL - RLT Field Sales (USA) USA US Innovative Medicines Der Umsatz Apr 30, 2024
349145BR - Director, Channel Enablement and Optimization Governance East Hanover USA US Innovative Medicines Marketing Sep 13, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • › Next page

Novartis Österreich

Novartis entdecken
  • Über Uns
  • Betroffene & Angehörige
  • Fachkreise
  • Medien
  • Karriere
Medienbereich
  • Pressemitteilungen
  • Geschichten
Unser Portfolio
  • Arzneimittel der Novartis
Weitere Novartis Websites
  • Healthcare Professional Resources
  • Global site
Footer Bottom
© 2024 Novartis Pharma GmbH
  • Datenschutzerklärung
  • Nutzungsbedingungen
  • Über Cookies
  • Impressum
  • Cookie-Einstellungen
  • Barrierefreiheit im Internet
  • Site Map
Novartis Site Directory
Diese Website richtet sich an Personen in Österreich.